Financial reports
10-K
2023 FY
Annual report
27 Feb 24
10-Q
2023 Q3
Quarterly report
6 Nov 23
10-Q
2023 Q2
Quarterly report
3 Aug 23
10-Q
2023 Q1
Quarterly report
4 May 23
ARS
2022 FY
Annual report to shareholders
2 May 23
10-K
2022 FY
Annual report
28 Feb 23
10-Q
2022 Q3
Quarterly report
3 Nov 22
10-Q
2022 Q2
Quarterly report
4 Aug 22
10-Q
2022 Q1
Quarterly report
5 May 22
NT 10-K
Notice of late annual filing
2 Mar 22
Current reports
8-K
Regulation FD Disclosure
19 Mar 24
8-K
ATEC Reports Fourth Quarter and Full-Year 2023 Financial Results
27 Feb 24
8-K
ATEC Announces Record Preliminary Revenue Results for 2023
8 Jan 24
8-K
Departure of Directors or Certain Officers
3 Jan 24
8-K
ATEC Reports Third Quarter 2023 Financial Results and Raises Full Year 2023 Adjusted EBITDA Guidance
6 Nov 23
8-K
ATEC Announces Pricing of Public Offering of Common Stock
26 Oct 23
8-K
ATEC Announces Proposed Public Offering of Common Stock
24 Oct 23
8-K
ATEC Enhances Board with Renowned Spine Prowess
17 Oct 23
8-K
ATEC Announces Preliminary Third Quarter 2023
16 Oct 23
8-K
ATEC Reports Second Quarter 2023 Financial Results and Raises Full Year 2023 Revenue and Adjusted EBITDA Guidance
3 Aug 23
Registration and prospectus
S-8
Registration of securities for employees
28 Feb 24
424B5
Prospectus supplement for primary offering
26 Oct 23
424B5
Prospectus supplement for primary offering
24 Oct 23
S-8
Registration of securities for employees
20 Jun 23
424B5
Prospectus supplement for primary offering
20 Apr 23
S-3ASR
Automatic shelf registration
19 Apr 23
S-8
Registration of securities for employees
6 Aug 21
S-3
Shelf registration
31 Mar 21
D
$168M in equity, sold $30M, 6 investors
31 Dec 20
424B5
Prospectus supplement for primary offering
15 Oct 20
Proxies
DEFA14A
Additional proxy soliciting materials
28 Apr 23
DEF 14A
Definitive proxy
28 Apr 23
DEFA14A
Additional proxy soliciting materials
28 Apr 22
DEF 14A
Definitive proxy
28 Apr 22
DEFA14A
Additional proxy soliciting materials
29 Apr 21
DEF 14A
Definitive proxy
29 Apr 21
DEFA14A
Additional proxy soliciting materials
28 Apr 20
DEF 14A
Definitive proxy
28 Apr 20
DEFA14A
Additional proxy soliciting materials
17 May 19
DEF 14A
Definitive proxy
30 Apr 19
Other
SD
Conflict minerals disclosure
19 May 23
SD
Conflict minerals disclosure
17 May 22
UPLOAD
Letter from SEC
21 May 21
SD
Conflict minerals disclosure
20 May 21
CORRESP
Correspondence with SEC
18 May 21
EFFECT
Notice of effectiveness
11 May 21
CORRESP
Correspondence with SEC
6 May 21
UPLOAD
Letter from SEC
3 May 21
UPLOAD
Letter from SEC
7 Apr 21
EFFECT
Notice of effectiveness
19 Aug 20
Ownership
144
Notice of proposed sale of securities
24 Apr 24
SC 13D/A
L-5 Healthcare Partners, LLC
22 Mar 24
4
Evan Bakst
18 Mar 24
4
Patrick Miles
8 Mar 24
4
Quentin S. Blackford
8 Mar 24
4
Tyson Eliot Marshall
8 Mar 24
4/A
Paul Segal
6 Mar 24
144
Notice of proposed sale of securities
6 Mar 24
4
Tyson Eliot Marshall
4 Mar 24
4
John Todd Koning
4 Mar 24